Bruker Corp. buy Barclays PLC
Start price
10.02.25
/
50%
€53.02
Target price
10.02.26
€63.00
Performance (%)
-45.04%
Price
29.08.25
€29.04
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Bruker Corp. is performing very badly with a performance of -45.04%. Dividends of €0.10 are taken into consideration when calculating the performance. This prediction currently runs until 10.02.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bruker Corp. | -4.222% | -4.222% |
| iShares Core DAX® | -1.740% | -1.152% |
| iShares Nasdaq 100 | -0.157% | -0.813% |
| iShares Nikkei 225® | -1.705% | 3.309% |
| iShares S&P 500 | 0.148% | 0.240% |
Comments by Barclays_PLC for this prediction
In the thread Bruker Corp. diskutieren
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Barclays PLC from $69.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for BRKR provided by MarketBeat